Deerfield Management Company, L.P. is an employee owned hedge fund sponsor. The firm primarily provides its services to pooled investment vehicles. Deerfield does structured financings for healthcare companies, particularly biotechs. Deerfield also conducts debt, secondary, IPO (initial public offering), and royalty financing.
Deerfield was established on January 13, 1994, by James Edward Flynn and is based in New York City.The firm is a global fixed-income investment adviser that has managed institutional, alternative accounts since 1994. Deerfield is a large advisory firm with 14 clients and discretionary assets under management fund.
Deerfield launched in 1994 with $17 million in equity. Twenty years later, it manages funds in excess of $5 billion.
Deerfield has made 42 investments. One of their investments was on Jan 18, 2019, when they invested $8M in Itamar Medical. Deerfield has had 20 exits, including Foundation Medicine, Orchard Therapeutics, and Alector.
The firm invests in public equity markets of the United States. The firm makes its private equity investments in large-cap and growth companies. It typically invests in healthcare sector which includes pharmaceuticals, biotechnology, generic drugs, over the counter drugs, medical devices, medical equipment, diagnostics, hospital supplies, hospital services, acute care hospitals, nursing homes, psychiatric hospitals, alternate site providers, home care, physician practice management, medical software HMOs (health maintenance organization), health insurers, benefit management companies, distributors, drug stores, and animal healthcare products and services.
Nkarta Therapeutics is a biotechnology company using natural killer (NK) immune cells for cellular therapies.
A genetic medicines company in Massachusetts that focuses on patients suffering from rare genetic diseases.
Cabaletta Bio is a biotechnology company developing cellular therapies for autoimmune disease.
Tesaro is a biopharmaceutical company focused on identifying cancer therapies, acquired by GSK in 2019.
RubiconMD is a New York-based company founded by Julien L. Pham, Gil Addo, Carlos Reines and Gilbert Addo.
A biopharmaceutical company dedicated to the development of novel therapeutics in the field of Epigenetics
Spark Therapeutics is a Philadelphia-based therapeutics and biotechnology company founded in 2013.
A pharmaceutical company developing protein degradation drugs to treat cancer and other diseases
Generation Bio is a Cambridge, Massachusetts-based genetic medicine and biotechnology company.
Edgewise Therapeutics is a drug discovery and biotechnology company developing products based on the understanding of skeletal muscle.
REVOLUTION Medicines is a Redwood City, California-based company.
SentreHEART is a Redwood City, California-based healthcare company.
Mirum Pharmaceuticals is a Menlo Park, California-based company.
PQ Bypass is a medtech company advancing the treatment of long-segment peripheral artery disease.